Top compounds associated with response to CARD9


Feature Type Standardized
Nominal ANOVA
mRNA AC220 GDSC1000 pan-cancer AAC 0.19 1e-07
mRNA ATRA CTRPv2 pan-cancer AAC 0.17 7e-07
mRNA linifanib GDSC1000 pan-cancer AAC 0.17 1e-06
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.25 4e-06
mRNA ATRA FIMM pan-cancer AAC 0.8 6e-06
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA BX-912 GDSC1000 pan-cancer AAC 0.12 6e-05
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.14 6e-05
mRNA TG-101348 GDSC1000 pan-cancer AAC 0.12 6e-05
Download CSV